baber/WOPTO huggingface dataset:
Patent NZ-203724-A (NZ)
Title: Polymethylene imine substituted pyrimidine and triazine derivatives and pharmaceutical compositions
Inventor: REGNIER G
IPC: C07D409/14
Filed: 1983-03-28
Abstract: Polymethylene-imines of the formula:   <IMAGE>   in which: A is a hydrocarbon radical from C3 to C5 in a straight or branched chain possibly containing one or two double bonds and possibly substituted by one or more hydroxy radicals; X is CH or nitrogen; n is zero, one or two; Y is oxygen or N-R1 in which R1 is hydrogen, alkyl from C1 to C5, alkenyl from C2 to C5, cycloalkyl or cycloalkenyl from C3 to C7, or acetyl; R is hydrogen, alkyl from C1 to C5, cycloalkyl from C5 to C7 or phenyl optionally substituted by one or more fluorine or chlorine; and B is hydrogen, alkyl from C1 to C5, alkenyl from C2 to C5, or phenyl, naphthyl, benzofuranyl, benzothienyl, benzodioxolyl, benzodioxanyl, benzodioxinyl,  DELTA 3-chromanyl, thiochromenyl or chromanyl, each optionally substituted by fluorine, chlorine, alkyl or alkoxy from C1 to C5; or a radical of the formula:    <IMAGE>   in which: R2, R3 and R4 which may be the same or different, each represent hydrogen, or phenyl optionally substituted by fluorine or chlorine. These compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of all kinds of tissular hypoxia.
Patent NZ-204623-A (NZ)
Title: Continuously forming patterned floor or wall covering from a plastisol coated sheet
Inventor: BERENGER D
IPC: D06N3/00
Filed: 1983-06-17
Abstract: Floor and wall coverings having a pattern are made by coating a plastisol onto a sheet support, and simultaneously with a thermal activation of the plastisol to gelify it, bringing a transferable pattern on a paper layer into contact with the plastisol.
Patent NZ-221424-A (NZ)
Title: Pharmaceutical compositions contaipyrimidines
Inventor: EISERT W
IPC: A61K9/58
Filed: 1987-08-12
Abstract: A pharmaceutical combination consisting of dipyridamole or mopidamol and O-acetylsalicylic acid or the physiologically tolerated salts thereof is used for the specific prevention of thrombus formation.
Patent NZ-226365-A (NZ)
Title: 3-substituted pyridines and fungicides
Inventor: ZIPPERER BERNHARD
IPC: C07D213/89
Filed: 1988-09-28
Abstract: 3-Substituted pyridine of the formula <IMAGE>  in which R<1> represents hydrogen, alkyl, alkenyl, alkynyl, acyl, haloacyl, benzoyl, benzyl; R<2> represents hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, arylalkyl, aryloxyalkyl,  R<3> represents the radical <IMAGE> where R<4> to R<8> independently of one another represent hydrogen, alkyl, alkoxy, haloalkyl, alkoxycarbonyl, dialkylamino, phenyl, hydroxyl or halogen, and together additionally represent the group -CH=CH-CH=CH-, n has the value 0 or 1, and their salts which are tolerated by plants, and fungicides containing these compounds.
Patent NZ-231983-A (NZ)
Title: Substituted 1,3-diazoles and 1,2,4-triazoles; fungicidal compositions, methods for preparation and combating fungal disease
Inventor: HUTT JEAN
IPC: C07D249/08
Filed: 1990-01-04
Abstract: Azolylmethylcycloalkane or alkene benzylidene of formula <IMAGE>  in which:  A and A1 are hydrocarbon chains containing 1 to 3 carbon atoms,  R1, R2, R3, R4 and R5 are hydrocarbon radicals  X is halogen  Y is H or halogen  n = 1, 2, 3  W is -CH= or -N Use as fungicide.
Patent NZ-239204-A (NZ)
Title: Enzymatic process for the preparation of basic fibroblast growth factor (bfgf)
Inventor: MONSAN PIERRE
IPC: C07K14/50
Filed: 1991-07-31
Abstract: Novel prepn. of a basic fibroplast growth factor (bFGF) comprises (a) forming an adduct between heparin or heparan sulphate and a bFGF which has a 9-10 Leu-Pro bond, (b) treating the adduct with pepsin A or cathepsin D to cleave the bond and (c) releasing from the adduct the bFGF thus obtd. The bFGF may be of formula (I). NH2-(AA)x-Leu-Pro-Y-COOH (I). (AA = any amino acid residue, x = 0 or an integer; (AA)x may be eg. Ile Thr Thr, Thr Thr or Thr; y = the amino acid sequence of (11-155) bFGF.
Patent NZ-240422-A (NZ)
Title: Absorbent pad: fibrous core integrally attached to backsheet and hydrophobic facing layer
Inventor: AHR NICHOLAS ALBERT
IPC: A61F13/53
Filed: 1991-10-31
Abstract: Absorbent structures are disclosed comprising a fibrous, superabsorbent core and an integrally attached facing layer. The structures can be made by forming nonwoven webs of mixtures of thermoplastic fibers and superabsorbent fibers, and a web consisting essentially of thermoplastic hydrophobic fibers. The layers are bonded together using thermal bonding. The structures are suitable for use in disposable absorbent products, in particular, pantiliners.
Patent NZ-240925-A (NZ)
Title: Heterocyclically-substituted fluoromethyl benzene derivatives, preparation and pharmaceutical compositions thereof
Inventor: LANG MARC
IPC: C07D249/08
Filed: 1991-12-10
Abstract: Compounds of formula I    <IMAGE>  (I)  wherein Z, R, R1, R2 and X are as defined in the description, have valuable pharmaceutical properties and are effective especially against tumors. They are prepared in a manner known per se.
Patent NZ-250633-A (NZ)
Title: Triple glazing unit having a u-shaped spacer sealed to outermost panes and an intermediate pane maintained by first and second beads of a pliable flowable material within the base of the spacer
Inventor: LEOPOLD EDMUND A
IPC: B29C48/05
Filed: 1994-01-06
Abstract: A nozzle (104) for depositing the shaped layer of the piable material includes a platform (110) having a shaping tip (114). The shaping tip has converging sides at one end (116) and generally parallel sides at the other end (118). The portion of the tip at the first end (116) has a lower elevation than the portion of the tip at the second end (118). Holes (124,126) for moving the pliable material are provided in the platform (110) on each side of the tip (114) and in tips intermediate its ends. The different elevation and converging end (116) minimizes if not eliminates tailing. <IMAGE>
Patent NZ-273129-A (NZ)
Title: 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b benzoic acid salt hemihydrate; pesticidal compositions
Inventor: CVETOVICH RAYMOND
IPC: A01N43/90
Filed: 1994-08-15
Abstract: The most thermodynamically stable crystalline form of the benzoic acid salt of 4"-deoxy-4"-epi-methylamino avermectin B1a/B1b as the hemihydrate is obtained by crystallization from organic solvents containing a controlled amount of water.
Patent NZ-277813-A (NZ)
Title: Composition for treating water and sanitising/reclaiming soils
Inventor: WILLUWEIT THOMAS
IPC: B09C1/00
Filed: 1994-12-27
Abstract: A composition for treatment of water and soils comprises componentsA. CaCO3,B. at least one compound selected from the group consisting of calcium salts, including CaCl2 and Ca(NO3)2, and inorganic magnesium compounds,C. at least one compound selected from the group consisting of NaHCO3 and KHCO3,wherein the components A and B are present in a molar ratio of from 0.1:1 to 1:1, and wherein the components B and C are present in a molar ratio of from 1:3 to 1:1.
Patent NZ-282949-A (NZ)
Title: Use of condensed mercaptoacetylamidebenzazepines in treating elevated cholesterol levels, hypertriglyceridemia, and atheroschlerosis
Inventor: FLYNN GARY ALAN
IPC: A61P9/10
Filed: 1995-02-28
Abstract: The present invention relates to the use of certain mercaptoacetylamide and benzazapine derivatives in treating patients suffering from hypertriglyceridemia, atherosclerosis and hypercholesterolemia.
Patent NZ-285510-A (NZ)
Title: Pyranone compounds for treatment of retroviral infection
Inventor: ROMINES KAREN RENE
IPC: C07D405/12
Filed: 1995-05-04
Abstract: The present invention relates to compounds of formula I and II which are pyran-2-ones, 5,6-dihydro-pyran-2-ones, 4-hydroxy-benzopyran-2-ones, 4-hydroxy-cycloalkyl[b]pyran-2-ones, and derivatives thereof, useful for inhibiting a retrovirus in a mammalian cell infected with said retrovirus.wherein R10 and R20 taken together are:
Patent NZ-286366-A (NZ)
Title: Wood preserving agents comprising fatty amine ethoxylate and unsaturated fatty acid (or copper or zinc salt) and optionally boron compounds
Inventor: BARTH VOLKER
IPC: B27K3/50
Filed: 1996-04-15
Abstract: Wood preservative comprises 1-35 wt.% of a prod. obtd. by mixing 25-75 wt. pts. of an ethoxylated fatty amine (I) and 75-25 pts. wt. of a 3-25C unsatd. fatty acid (II) or its Cu and/or Zn salts.
Patent NZ-297142-A (NZ)
Title: Oral immunisation and oral vaccines using edible transgenic plants comprising immunogenic agents such as E coli and cholera toxin antigens
Inventor: ARNTZEN CHARLES J
IPC: A61K39/00
Filed: 1995-10-24
Abstract: A transgenic plant material which comprises at least one immunogenic agent selected from the group consisting of E. coli enterotoxin (LT) antigens and cholera (CT) antigens.  The immunogenic agent when synthesized further comprises at least one specific cellular localization retention sequence (ER retention sequence).  The immunogenic agent is at a concentration within the transgenic plant material that is enhanced compared to the concentration of an immunogenic agent synthesized in a transgenic plant without comprising a specific cellular localization retention sequence.  The transgenic plant material also comprises a DNA sequence encoding at least one immunogenic agent selected from the group consisting of E. coli enterotoxin (LT) antigens and cholera (CT) antigens, wherein the DNA sequence further comprises at least one sequence encoding at least one specific cellular localization retention sequence that concentrates the immunogenic agent within the transgenic plant material.  The transgenic plant material is capable of inducing an antibody response in animals after oral ingestion of the immunogenic agent.
Patent NZ-299281-A (NZ)
Title: Use of hyaluronic acid in topical medicaments
Inventor: FALK RUDOLF EDGAR
IPC: A61K31/136
Filed: 1993-02-16
Abstract: Provided is a topical composition for the treatment of skin diseases or a condition of the skin comprising a therapeutic agent in an effective amount to treat the disease or condition of the skin and hyaluronic acid and/or a salt thereof wherein its molecular weight is between 150000 and 750000 daltons.  The hyaluronic acid provides for the transport of the therapeutic agent percutaneously into the epidermis of the skin to the site of trauma and/or pathology of the disease or condition to be treated.
Patent NZ-329847-A (NZ)
Title: Piperazine derivatives and process for the preparation thereof
Inventor: CHO EUI-HWAN
IPC: A61K31/44
Filed: 1997-06-28
Abstract: PCT No. PCT/KR97/00128 Sec. 371 Date Feb. 27, 1998 Sec. 102(e) Date Feb. 27, 1998 PCT Filed Jun. 28, 1997 PCT Pub. No. WO98/00402 PCT Pub. Date Jan. 8, 1998The present invention relates to novel compound having strong antimumor activities of the general formula(I) wherein R1 and R2 are independently hydrogen, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C3-C6 cycloalkyl, substituted or unsubstituted C2-C8 unsaturated alkyl, ketone, substituted or unsubstituted aryl, substituted or unsubstituted C1-C4 alkoxy, substituted or unsubstituted arylhydroxy, substituted or unsubstituted amino, C1-C4 lower ester, C1-C4 lower thioester, thiol, substituted or unsubstituted carboxyl, epoxy, substituted or unsubstituted C1-C4 lower thioalkoxy; or R1 and R2 are fused to form C3-C4 saturated or unsaturated chain; R3, R4, R5, R6 and R7 are independently hydrogen, halogen, hydroxy, nitro, C1-C4 lower ester, C1-C4 lower alkyl, C1-C4 lower thioalkyl, substituted or unsubstituted C3-C6 cycloalkyl, C1-C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryl, substituted or unsubstituted lower arylalkoxy, substituted or unsubstituted lower alkylamino, or lower alkyl substituted or unsubstituted carbamate; or among R3, R4, R5, R6 and R7, two adjacent groups are bonded with each other to form 1,2-phenylene or 2,3-naphthylene; X is oxygen, sulfur, or substituted or unsubstituted imino; Y is bonded at the 3-position or 4-position of the aromatic ring part wherein Y is oxygen or -NR8- (wherein, R8 is the same with the above-mentioned R3.); Z is hydroxy, C1-C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryloxy, C1-C4 lower alkylamino, substituted or unsubstituted cycloamino containing 1-5 nitrogen atoms; A is nitrogen or -CH=; its pharmaceutically acceptable acid addition salts and process for the preparation thereof.
Patent NZ-331079-A (NZ)
Title: Recombinant canine herpesviruses for production and use as therapeutics
Inventor: HAANES ELIZABETH J
IPC: A61P37/00
Filed: 1997-02-14
Abstract: A recombinant canine herpesvirus (CHV) and recombinant CHV genomes, particularly to those CHV and CHV genomes that contain heterologous nucleic acid molecules. An isolated CHV nucleic acid molecule, to CHV proteins encoded by such nucleic acid molecule, and antibodies raised against such CHV proteins as well as to the use of such CHV nucleic acid molecules, proteins and antibodies as therapeutic compositions to protect an animal from CHV is described. Constructs comprising CHV nucleic acid molecules that include heterologous nucleic acid molecules, to recombinant vectors including such constructs, and to the use of such constructs and vectors in the production of recombinant CHV and recombinant CHV genomes are also described.
Patent NZ-331285-A (NZ)
Title: Arylpyrroles for the protection of wood, wood products and wooden structures from insect attack
Inventor: REID BYRON LESLIE
IPC: B27K3/34
Filed: 1998-08-07
Abstract: The application provides a method for the protection of wood, wood-products or wooden structures from wood-eating insect infestation which comprises applying to the wood an insecticidally effective amount of an arylpyrrole compound of formula I where R is H or C1-4-alkoxymethyl, X is Cl or Br; and L, M and Q are each independently H, Cl, Br. I. F or C1-1-haloalkyl.
Patent NZ-501897-A (NZ)
Title: Packaging apparatus for cans of differing diameter, with machine to expand apertures in carrier of high length to width
Inventor: WEAVER WILLIAM N
IPC: B65B17/02
Filed: 1999-12-17
Abstract: Jaws 48, 49 are positioned in pairs around drum 40 at constant circumferential pitch. In use the jaws grip apertures in carrier 10. The spacing between jaws 48, 49 is adjustable to as to accommodate a variation in container diameter of approximately 25 mm.
Patent NZ-502831-A (NZ)
Title: Cutting member comprising a cutting element and supports thereof and conveying areas for cut product on both supports and cutting elements
Inventor: NEUERBURG HORST
IPC: A01D34/66
Filed: 2000-02-14
Abstract: A cutting member (8) of a cutting machine to be driven in rotation about an upwardly directed axis of revolution (11) and including: -at least two supports (16, 16') each intended to have a cutting element, and -at least two active areas (55, 55') each located in a region of a corresponding cutting element (13, 13') and each exposed, during the work, to a product previously cut by the cutting elements (13, 13'), each active area contributing to a conveying of the cut product in a direction opposite to the direction of advance, wherein each support (16, 16') includes an upper part (38, 38') forming at least the whole corresponding active area.
Patent NZ-505285-A (NZ)
Title: Mobile station assisted timing synchronization in a CDMA communication system
Inventor: WHEATLEY CHARLES E III
IPC: H04W56/00
Filed: 1999-01-15
Abstract: In the present invention, the slave base station (64) attains synchronization with the reference base station (62) through messages (504) transmitted from and received by a mobile station (60) either in the soft handoff region between the reference base station (62) and the slave base station (64) or within a range which allows the mobile station (60) to communicate with the slave base station (64). When the mobile station (62) is not in communication with both the reference base station and the slave base station (62), then the round trip delay between the mobile station and the reference base station is measured by the reference base station (62). The reference base station (62) communicates the PN code used by the mobile station over the reverse link to the slave base station. The slave base station (64) acquires the signal (504) from the mobile station (60) and determines when the signal from the mobile station arrives. The slave base station (64) then makes and estimates as to the length of the delay between transmission of a signal from the mobile station (60) to the slave base station (64). Based upon these measurements and estimates, the slave base station (64) determines the error, which is present in the slave base station system time.
Patent NZ-505980-A (NZ)
Title: Beta-sheet mimetics
Inventor: QABER MAHER N
IPC: C07K5/06
Filed: 1998-02-12
Abstract: Beta -sheet mimetics and methods relating to the same are disclosed. The beta -sheet mimetics have utility as protease and kinase inhibitors, as well as inhibitors of transcription factors and protein-protein binding interactions. Methods of the invention include administration of a beta -sheet mimetic, or use of the same for the manufacture of a medicament for treatment of a variety of conditions associated with the targeted protease, kinase, transcription factor and/or protein-protein binding interaction.
Patent NZ-507311-A (NZ)
Title: Device for packaging materials in a vacuum chamber using continuous roll of film and folding and sealing open edges
Inventor: PIRON ANDREA
IPC: B65B11/48
Filed: 1998-03-25
Abstract: A  packaging  device, particularly for  foodstuffs  or technical   materials,  comprising  a   bell-shaped   vacuum chamber (3).  A single-folded film (7) can be placed in  the vacuum  chamber and the foodstuff can be inserted  from  the open  longitudinal side (9) of the film.  Inside  the  bell- shaped  vacuum  chamber (3) there is also provided  a  first transverse  thermal  bonding bar (11),  which  is  laterally adjacent  to  a  cutting blade (12), and  a  second  thermal bonding  bar  (15), both bars being L-shaped. At  least  one nozzle  (18) for introducing gas is furthermore provided  so as  to face the longitudinal or transverse open side (9)  of the single-folded film (7).
Patent NZ-508985-A (NZ)
Title: Polystyrene volume-reducing agents comprising two plasticizers, one having higher and one lower solubility than the polystyrene
Inventor: USUI HIROAKI
IPC: C08F8/04
Filed: 2000-12-18
Abstract: A volume reducing agent for processing polystyrene consisting of 65-97 wt% of a first plasticizer having a solubility parameter lower than the solubility parameter of the polystyrene and 3-35 wt% of a second plasticizer having a solubility parameter higher than the solubility parameter of the polystyrene.  The volume reducing agent is in a liquid state, has a solubility parameter in the range of plus or minus 3 (cal/cm3)1/2 of the polystyrene to be processed in the mixed state and transfers the resulting materials having reduced volume into gel-type products to be floated and separated easily.
Patent NZ-511288-A (NZ)
Title: Method for accelerated remediation & method of using an apparatus therefor
Inventor: HORN TERRY DEAN
IPC: B01F23/30
Filed: 1999-11-17
Abstract: A method of using an apparatus in the accelerated remediation of a contaminated material, which comprises the steps of: (a) generating an air stream from the apparatus at a velocity sufficient for entraining the contaminated material therein, (b) entraining the contaminated material in the air stream, (c) microenfractionating the contaminated material with the apparatus to form a microenfractionated contaminated material, and (d) treating the microenfractionated contaminated material with at least one chemical amendment comprising a metallic reducing agent, by discharging the chemical amendment from the apparatus prior to, and/or during, and/or subsequent to, microenfractionation of the contaminated material.
Patent NZ-511867-A (NZ)
Title: Virtual product formulation to meet target constraints
Inventor: PIETRI DANIEL
IPC: C09D7/80
Filed: 2001-05-22
Abstract: A computerized method to formulate a product such as a chemical product includes running a product formulation script that guides the formulation of a product from several different components.  The script includes a component selection option identifying sets of formulation components, at least one constraint to identify a numeric range associated with a property of one of the formulation components, and a target constraint.  The script is processed to determine a collection of formulation components that can be used to produce the product such that one or more properties of the product meet associated target constraints.  The script processing includes selecting from among optional formulation components.  The selection can be performed by determining sets of formulation components to be used in formulating the product, and determining a permitted range associated with the formulation components.  The permitted ranges enable the formulated product to meet the target constraints.
Patent NZ-513009-A (NZ)
Title: Method for carrying out the controlled post-harvest production of proteins in host organisms
Inventor: DURING KLAUS
IPC: C12N15/09
Filed: 2000-09-05
Abstract: A method of obtaining a desired protein from a transgenic non-human host organism, wherein the expression of the gene coding for this protein is not made until the host organism has been harvested, wherein: a) the transgenic host organism contains the gene coding for the desired protein such that it is only expressed in the presence of a chemical inductor; and b) contact with the inductor takes place via a gas phase surrounding the host organism after the host organism has been harvested.
Patent NZ-514415-A (NZ)
Title: Polyethyleneimine:DNA formulations for aerosol delivery
Inventor: DENSMORE CHARLES L
IPC: A61K47/48
Filed: 2000-03-31
Abstract: It is demonstrated that polycationic, non-lipid DNA formulations are resistant to nebulizer-induced degradation and are much more specific and efficient than lipid-based formulations in transfecting respiratory tract tissues in vivo. Results presented herein demonstrate that polyethyleneimine (PEI) formulations are 10-fold more effective than previous lipid-based formulations when delivered in vivo by jet nebulizer. Therefore, aerosolized polyethyleneimine-based formulations are provided herein for use in targeting gene therapy via the respiratory tract.
Patent NZ-516363-A (NZ)
Title: Tricyclic compounds having spiro union having FXa inhibitory activity
Inventor: NISHIDA HIDEMITSU
IPC: A61P9/00
Filed: 2000-06-30
Abstract: Aromatic compounds having cyclic amino which are represented by general formula (I) or salts thereof are disclosed, wherein the variables shown in formula (I) are as defined in the specification. These compounds are useful as drugs, in particular, activated blood coagulation factor X inhibitors, exert a potent anticoagulation effect and can be orally administered. A pharmacophore derived from the above compounds is useful in molecular designing Fxa inhibitors.
Patent NZ-517631-A (NZ)
Title: Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
Inventor: MARTINI ALESSANDRO
IPC: A61K47/42
Filed: 2000-08-03
Abstract: A pharmaceutical formulation which comprises a parenterally acceptable carrier or diluent, estramustine phosphate, a sulfoalkyl ether, cyclodextrin, and human albumin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation also enables the estramustine phosphate to be administered with no side effects at the site of injection.